GlassScriptPhysician profile
Valerie Nemeth
NPI 1730614322
$1,182.86
in general payments reported to CMS, 2019-2025
20 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $109 · 2021: $159 · 2022: $262 · 2023: $50.14 · 2024: $19.19 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $352.80 | 2019-2025 | Wegovy |
| Abbvie INC. | $271.42 | 2021-2023 | |
| Glaxosmithkline, LLC. | $123.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $94.02 | 2019-2022 | |
| Lilly USA, LLC | $43.50 | 2021-2025 | Zepbound, Mounjaro |
| Amgen INC. | $37.65 | 2020-2021 | |
| Optinose US, INC. | $37.62 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $27.32 | 2025 | |
| Pfizer INC. | $26.76 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.63 | 2022 | |
| Eisai INC. | $18.10 | 2021 | |
| Xeris Pharmaceuticals, INC. | $17.49 | 2022 | |
| Antares Pharma, INC. | $16.64 | 2022 | |
| Amarin Pharma, INC. | $15.51 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $14.98 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Echosens North America, INC. | $14.79 | 2025 | Fibroscan |
| Sanofi Pasteur INC. | $13.87 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.25 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.79 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valerie Nemeth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.